Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus

Merck is scheduled to report its Q4 2020 results on Thursday, February 4. We expect the company to likely post revenue slightly below and earnings in-line with the consensus estimates, partly due to lower expected sales of vaccines, such as Gardasil and Proquad. That said, Merck should see an...